SPYRE THERAPEUTICS INC (SYRE:NASDAQ)
$85.69 5.79 (7.2466%)
Analysed SPYRE THERAPEUTICS INC (SYRE:NASDAQ) News Sources
Spyre Therapeutics to Participate in Upcoming September Investor Conferences
03-09-2026
yahoo.com
Spyre Announces Potential Best-in-Class SPY003 (anti-IL-23) Part A Induction Results from SKYLINE Trial, Completing Proof-of-Concept for All Three Components of its IBD Combinations
08-09-2026
yahoo.com
Spyre Therapeutics (SYRE) Reports SPY003 Endoscopic Improvement. Can Randomized Testing Confirm It?
10-09-2026
yahoo.com
Spyre (SYRE) Clears Monotherapy Phase for IBD Portfolio, Setting Up Combination Tests
17-09-2026
yahoo.com
Spyre Therapeutics Announces Grants of Inducement Awards
02-10-2026
yahoo.com
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock
05-10-2026
yahoo.com
Spyre Therapeutics stock falls on public offering launch
05-10-2026
yahoo.com
Spyre Therapeutics Announces Pricing of $350.0 Million Public Offering of Common Stock
06-10-2026
yahoo.com
Spyre Therapeutics Sinks 14% on Upsized $350 Million Stock Offering Priced Below Market
06-10-2026
tikr.com
Spyre Therapeutics (SYRE) Completed A $350 Million Public Stock Offering
08-10-2026
yahoo.com
What is the current price of SPYRE THERAPEUTICS INC (SYRE:NASDAQ)?
The current price of SPYRE THERAPEUTICS INC (SYRE:NASDAQ) is $85.69.
SPYRE THERAPEUTICS INC (SYRE:NASDAQ) absolute price change since previous trading day?
The absolute price change of SPYRE THERAPEUTICS INC (SYRE:NASDAQ) since the previous trading day is $5.79.
SPYRE THERAPEUTICS INC (SYRE:NASDAQ) percentage price change since previous trading day?
The percentage price change of SPYRE THERAPEUTICS INC (SYRE:NASDAQ) since the previous trading day is 7.2466%.
What is the most recent average sentiment score for SPYRE THERAPEUTICS INC (SYRE:NASDAQ)?
The most recent average sentiment score for SPYRE THERAPEUTICS INC (SYRE:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for SPYRE THERAPEUTICS INC (SYRE:NASDAQ)?
The most recent sentiment for SPYRE THERAPEUTICS INC (SYRE:NASDAQ) is .
SEC-8K** Filing Available For SPYRE THERAPEUTICS INC (SYRE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.